nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—melanoma	0.457	1	CbGaD
Methylprednisolone—CYP3A4—Temozolomide—melanoma	0.125	0.376	CbGbCtD
Methylprednisolone—ABCB1—Dactinomycin—melanoma	0.0759	0.229	CbGbCtD
Methylprednisolone—CYP3A4—Vemurafenib—melanoma	0.0685	0.206	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—melanoma	0.0392	0.118	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—melanoma	0.0235	0.0708	CbGbCtD
Methylprednisolone—Infestation—Vemurafenib—melanoma	0.00116	0.0063	CcSEcCtD
Methylprednisolone—Infestation NOS—Vemurafenib—melanoma	0.00116	0.0063	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Vemurafenib—melanoma	0.00114	0.00618	CcSEcCtD
Methylprednisolone—Embolism—Docetaxel—melanoma	0.0011	0.00596	CcSEcCtD
Methylprednisolone—Oesophagitis—Dactinomycin—melanoma	0.00107	0.00582	CcSEcCtD
Methylprednisolone—Skin exfoliation—Carmustine—melanoma	0.00105	0.00569	CcSEcCtD
Methylprednisolone—Neuropathy—Carmustine—melanoma	0.00103	0.00559	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Vemurafenib—melanoma	0.00102	0.00556	CcSEcCtD
Methylprednisolone—Skin exfoliation—Temozolomide—melanoma	0.00101	0.0055	CcSEcCtD
Methylprednisolone—Neuropathy—Temozolomide—melanoma	0.000996	0.00541	CcSEcCtD
Methylprednisolone—Injury—Bleomycin—melanoma	0.000993	0.00539	CcSEcCtD
Methylprednisolone—Eye disorder—Vemurafenib—melanoma	0.000974	0.00529	CcSEcCtD
Methylprednisolone—Cardiac disorder—Vemurafenib—melanoma	0.000967	0.00525	CcSEcCtD
Methylprednisolone—Angiopathy—Vemurafenib—melanoma	0.000945	0.00513	CcSEcCtD
Methylprednisolone—Neuritis—Docetaxel—melanoma	0.000945	0.00513	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Vemurafenib—melanoma	0.000939	0.0051	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Carmustine—melanoma	0.00092	0.005	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Carmustine—melanoma	0.000916	0.00497	CcSEcCtD
Methylprednisolone—Malnutrition—Vemurafenib—melanoma	0.000907	0.00492	CcSEcCtD
Methylprednisolone—Erythema—Vemurafenib—melanoma	0.000907	0.00492	CcSEcCtD
Methylprednisolone—Necrosis—Docetaxel—melanoma	0.000899	0.00488	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Temozolomide—melanoma	0.000889	0.00483	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000885	0.0048	CcSEcCtD
Methylprednisolone—Injury—Carmustine—melanoma	0.000867	0.00471	CcSEcCtD
Methylprednisolone—Amnesia—Carmustine—melanoma	0.000848	0.0046	CcSEcCtD
Methylprednisolone—Amnesia—Temozolomide—melanoma	0.000819	0.00445	CcSEcCtD
Methylprednisolone—Amenorrhoea—Docetaxel—melanoma	0.000803	0.00436	CcSEcCtD
Methylprednisolone—Bronchospasm—Bleomycin—melanoma	0.000776	0.00421	CcSEcCtD
Methylprednisolone—Arthralgia—Vemurafenib—melanoma	0.000772	0.00419	CcSEcCtD
Methylprednisolone—Myalgia—Vemurafenib—melanoma	0.000772	0.00419	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000767	0.00416	CcSEcCtD
Methylprednisolone—Affect lability—Temozolomide—melanoma	0.000758	0.00411	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Vemurafenib—melanoma	0.00074	0.00402	CcSEcCtD
Methylprednisolone—Infection—Vemurafenib—melanoma	0.000736	0.00399	CcSEcCtD
Methylprednisolone—Mood swings—Temozolomide—melanoma	0.000729	0.00396	CcSEcCtD
Methylprednisolone—Inflammation—Docetaxel—melanoma	0.000727	0.00395	CcSEcCtD
Methylprednisolone—Nervous system disorder—Vemurafenib—melanoma	0.000726	0.00394	CcSEcCtD
Methylprednisolone—Skin disorder—Vemurafenib—melanoma	0.000719	0.0039	CcSEcCtD
Methylprednisolone—Muscular weakness—Carmustine—melanoma	0.000703	0.00381	CcSEcCtD
Methylprednisolone—Breast disorder—Temozolomide—melanoma	0.000696	0.00378	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Bleomycin—melanoma	0.000693	0.00376	CcSEcCtD
Methylprednisolone—Hypotension—Vemurafenib—melanoma	0.000692	0.00376	CcSEcCtD
Methylprednisolone—Myocardial infarction—Bleomycin—melanoma	0.000689	0.00374	CcSEcCtD
Methylprednisolone—Muscular weakness—Temozolomide—melanoma	0.000679	0.00369	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Temozolomide—melanoma	0.000679	0.00369	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000675	0.00366	CcSEcCtD
Methylprednisolone—Skin exfoliation—Docetaxel—melanoma	0.000673	0.00366	CcSEcCtD
Methylprednisolone—Abdominal distension—Temozolomide—melanoma	0.00067	0.00364	CcSEcCtD
Methylprednisolone—Fluid retention—Docetaxel—melanoma	0.00067	0.00363	CcSEcCtD
Methylprednisolone—Neuropathy—Docetaxel—melanoma	0.000662	0.00359	CcSEcCtD
Methylprednisolone—Sweating increased—Temozolomide—melanoma	0.000648	0.00352	CcSEcCtD
Methylprednisolone—Oesophagitis—Docetaxel—melanoma	0.000644	0.0035	CcSEcCtD
Methylprednisolone—Fatigue—Vemurafenib—melanoma	0.000638	0.00347	CcSEcCtD
Methylprednisolone—Haemoglobin—Bleomycin—melanoma	0.000635	0.00344	CcSEcCtD
Methylprednisolone—Haemorrhage—Bleomycin—melanoma	0.000631	0.00343	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Docetaxel—melanoma	0.000628	0.00341	CcSEcCtD
Methylprednisolone—Weight increased—Temozolomide—melanoma	0.000606	0.00329	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Carmustine—melanoma	0.000602	0.00327	CcSEcCtD
Methylprednisolone—Infestation NOS—Temozolomide—melanoma	0.000593	0.00322	CcSEcCtD
Methylprednisolone—Infestation—Temozolomide—melanoma	0.000593	0.00322	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Docetaxel—melanoma	0.000591	0.00321	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000589	0.0032	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Temozolomide—melanoma	0.000582	0.00316	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Docetaxel—melanoma	0.000565	0.00306	CcSEcCtD
Methylprednisolone—Haemoglobin—Carmustine—melanoma	0.000554	0.00301	CcSEcCtD
Methylprednisolone—Haemorrhage—Carmustine—melanoma	0.000551	0.00299	CcSEcCtD
Methylprednisolone—Erythema—Bleomycin—melanoma	0.00055	0.00298	CcSEcCtD
Methylprednisolone—Hallucination—Carmustine—melanoma	0.000548	0.00298	CcSEcCtD
Methylprednisolone—Hypersensitivity—Vemurafenib—melanoma	0.000545	0.00296	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Carmustine—melanoma	0.000542	0.00294	CcSEcCtD
Methylprednisolone—Haemoglobin—Temozolomide—melanoma	0.000535	0.00291	CcSEcCtD
Methylprednisolone—Haemorrhage—Temozolomide—melanoma	0.000533	0.00289	CcSEcCtD
Methylprednisolone—Asthenia—Vemurafenib—melanoma	0.000531	0.00288	CcSEcCtD
Methylprednisolone—Visual impairment—Carmustine—melanoma	0.000531	0.00288	CcSEcCtD
Methylprednisolone—Hallucination—Temozolomide—melanoma	0.00053	0.00288	CcSEcCtD
Methylprednisolone—Cardiac failure—Docetaxel—melanoma	0.000525	0.00285	CcSEcCtD
Methylprednisolone—Pruritus—Vemurafenib—melanoma	0.000524	0.00284	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Temozolomide—melanoma	0.000523	0.00284	CcSEcCtD
Methylprednisolone—Eye disorder—Carmustine—melanoma	0.000515	0.0028	CcSEcCtD
Methylprednisolone—Visual impairment—Temozolomide—melanoma	0.000513	0.00279	CcSEcCtD
Methylprednisolone—Erythema—Dactinomycin—melanoma	0.000513	0.00278	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Bleomycin—melanoma	0.00051	0.00277	CcSEcCtD
Methylprednisolone—Diarrhoea—Vemurafenib—melanoma	0.000507	0.00275	CcSEcCtD
Methylprednisolone—Eye disorder—Temozolomide—melanoma	0.000498	0.0027	CcSEcCtD
Methylprednisolone—Malaise—Bleomycin—melanoma	0.000496	0.00269	CcSEcCtD
Methylprednisolone—Cardiac disorder—Temozolomide—melanoma	0.000494	0.00268	CcSEcCtD
Methylprednisolone—Arrhythmia—Carmustine—melanoma	0.000492	0.00267	CcSEcCtD
Methylprednisolone—Dizziness—Vemurafenib—melanoma	0.00049	0.00266	CcSEcCtD
Methylprednisolone—Angiopathy—Temozolomide—melanoma	0.000483	0.00262	CcSEcCtD
Methylprednisolone—Mental disorder—Carmustine—melanoma	0.000483	0.00262	CcSEcCtD
Methylprednisolone—Immune system disorder—Temozolomide—melanoma	0.000481	0.00261	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Temozolomide—melanoma	0.00048	0.00261	CcSEcCtD
Methylprednisolone—Erythema—Carmustine—melanoma	0.00048	0.0026	CcSEcCtD
Methylprednisolone—Malnutrition—Carmustine—melanoma	0.00048	0.0026	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Dactinomycin—melanoma	0.000476	0.00258	CcSEcCtD
Methylprednisolone—Vomiting—Vemurafenib—melanoma	0.000471	0.00256	CcSEcCtD
Methylprednisolone—Myalgia—Bleomycin—melanoma	0.000468	0.00254	CcSEcCtD
Methylprednisolone—Rash—Vemurafenib—melanoma	0.000467	0.00253	CcSEcCtD
Methylprednisolone—Mental disorder—Temozolomide—melanoma	0.000467	0.00253	CcSEcCtD
Methylprednisolone—Dermatitis—Vemurafenib—melanoma	0.000466	0.00253	CcSEcCtD
Methylprednisolone—Headache—Vemurafenib—melanoma	0.000464	0.00252	CcSEcCtD
Methylprednisolone—Erythema—Temozolomide—melanoma	0.000464	0.00252	CcSEcCtD
Methylprednisolone—Malnutrition—Temozolomide—melanoma	0.000464	0.00252	CcSEcCtD
Methylprednisolone—Breast disorder—Docetaxel—melanoma	0.000463	0.00251	CcSEcCtD
Methylprednisolone—Discomfort—Bleomycin—melanoma	0.000462	0.00251	CcSEcCtD
Methylprednisolone—Malaise—Dactinomycin—melanoma	0.000462	0.00251	CcSEcCtD
Methylprednisolone—Confusional state—Bleomycin—melanoma	0.000452	0.00246	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Docetaxel—melanoma	0.000452	0.00245	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Bleomycin—melanoma	0.000449	0.00244	CcSEcCtD
Methylprednisolone—Infection—Bleomycin—melanoma	0.000446	0.00242	CcSEcCtD
Methylprednisolone—Nausea—Vemurafenib—melanoma	0.00044	0.00239	CcSEcCtD
Methylprednisolone—Myalgia—Dactinomycin—melanoma	0.000436	0.00237	CcSEcCtD
Methylprednisolone—Bronchospasm—Docetaxel—melanoma	0.000435	0.00236	CcSEcCtD
Methylprednisolone—Discomfort—Dactinomycin—melanoma	0.000431	0.00234	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Temozolomide—melanoma	0.00043	0.00234	CcSEcCtD
Methylprednisolone—Angioedema—Temozolomide—melanoma	0.000424	0.0023	CcSEcCtD
Methylprednisolone—Hypotension—Bleomycin—melanoma	0.000419	0.00228	CcSEcCtD
Methylprednisolone—Malaise—Temozolomide—melanoma	0.000418	0.00227	CcSEcCtD
Methylprednisolone—Vertigo—Temozolomide—melanoma	0.000417	0.00226	CcSEcCtD
Methylprednisolone—Convulsion—Carmustine—melanoma	0.000416	0.00226	CcSEcCtD
Methylprednisolone—Infection—Dactinomycin—melanoma	0.000416	0.00226	CcSEcCtD
Methylprednisolone—Hypertension—Carmustine—melanoma	0.000414	0.00225	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000409	0.00222	CcSEcCtD
Methylprednisolone—Myalgia—Carmustine—melanoma	0.000408	0.00222	CcSEcCtD
Methylprednisolone—Anxiety—Carmustine—melanoma	0.000407	0.00221	CcSEcCtD
Methylprednisolone—Paraesthesia—Bleomycin—melanoma	0.000403	0.00219	CcSEcCtD
Methylprednisolone—Weight increased—Docetaxel—melanoma	0.000403	0.00219	CcSEcCtD
Methylprednisolone—Convulsion—Temozolomide—melanoma	0.000402	0.00218	CcSEcCtD
Methylprednisolone—Hypertension—Temozolomide—melanoma	0.0004	0.00217	CcSEcCtD
Methylprednisolone—Confusional state—Carmustine—melanoma	0.000395	0.00214	CcSEcCtD
Methylprednisolone—Myalgia—Temozolomide—melanoma	0.000395	0.00214	CcSEcCtD
Methylprednisolone—Arthralgia—Temozolomide—melanoma	0.000395	0.00214	CcSEcCtD
Methylprednisolone—Infestation NOS—Docetaxel—melanoma	0.000395	0.00214	CcSEcCtD
Methylprednisolone—Infestation—Docetaxel—melanoma	0.000395	0.00214	CcSEcCtD
Methylprednisolone—Anxiety—Temozolomide—melanoma	0.000393	0.00214	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000392	0.00213	CcSEcCtD
Methylprednisolone—Discomfort—Temozolomide—melanoma	0.00039	0.00212	CcSEcCtD
Methylprednisolone—Infection—Carmustine—melanoma	0.000389	0.00211	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Docetaxel—melanoma	0.000389	0.00211	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Docetaxel—melanoma	0.000387	0.0021	CcSEcCtD
Methylprednisolone—Myocardial infarction—Docetaxel—melanoma	0.000387	0.0021	CcSEcCtD
Methylprednisolone—Tachycardia—Carmustine—melanoma	0.000382	0.00207	CcSEcCtD
Methylprednisolone—Confusional state—Temozolomide—melanoma	0.000382	0.00207	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000381	0.00207	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Temozolomide—melanoma	0.000378	0.00205	CcSEcCtD
Methylprednisolone—Infection—Temozolomide—melanoma	0.000376	0.00204	CcSEcCtD
Methylprednisolone—Nervous system disorder—Temozolomide—melanoma	0.000371	0.00201	CcSEcCtD
Methylprednisolone—Feeling abnormal—Bleomycin—melanoma	0.00037	0.00201	CcSEcCtD
Methylprednisolone—Skin disorder—Temozolomide—melanoma	0.000368	0.002	CcSEcCtD
Methylprednisolone—Hypotension—Carmustine—melanoma	0.000366	0.00199	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Temozolomide—melanoma	0.000366	0.00199	CcSEcCtD
Methylprednisolone—Fatigue—Dactinomycin—melanoma	0.000361	0.00196	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Carmustine—melanoma	0.000357	0.00194	CcSEcCtD
Methylprednisolone—Urticaria—Bleomycin—melanoma	0.000356	0.00193	CcSEcCtD
Methylprednisolone—Haemoglobin—Docetaxel—melanoma	0.000356	0.00193	CcSEcCtD
Methylprednisolone—Rhinitis—Docetaxel—melanoma	0.000355	0.00193	CcSEcCtD
Methylprednisolone—Haemorrhage—Docetaxel—melanoma	0.000354	0.00192	CcSEcCtD
Methylprednisolone—Insomnia—Carmustine—melanoma	0.000354	0.00192	CcSEcCtD
Methylprednisolone—Paraesthesia—Carmustine—melanoma	0.000352	0.00191	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Docetaxel—melanoma	0.000348	0.00189	CcSEcCtD
Methylprednisolone—Feeling abnormal—Dactinomycin—melanoma	0.000345	0.00187	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000345	0.00187	CcSEcCtD
Methylprednisolone—Insomnia—Temozolomide—melanoma	0.000342	0.00186	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Dactinomycin—melanoma	0.000342	0.00186	CcSEcCtD
Methylprednisolone—Visual impairment—Docetaxel—melanoma	0.000341	0.00185	CcSEcCtD
Methylprednisolone—Paraesthesia—Temozolomide—melanoma	0.00034	0.00184	CcSEcCtD
Methylprednisolone—Dyspepsia—Temozolomide—melanoma	0.000333	0.00181	CcSEcCtD
Methylprednisolone—Eye disorder—Docetaxel—melanoma	0.000331	0.0018	CcSEcCtD
Methylprednisolone—Abdominal pain—Dactinomycin—melanoma	0.000331	0.0018	CcSEcCtD
Methylprednisolone—Hypersensitivity—Bleomycin—melanoma	0.00033	0.00179	CcSEcCtD
Methylprednisolone—Cardiac disorder—Docetaxel—melanoma	0.000329	0.00178	CcSEcCtD
Methylprednisolone—Fatigue—Temozolomide—melanoma	0.000326	0.00177	CcSEcCtD
Methylprednisolone—Feeling abnormal—Carmustine—melanoma	0.000323	0.00175	CcSEcCtD
Methylprednisolone—Asthenia—Bleomycin—melanoma	0.000322	0.00175	CcSEcCtD
Methylprednisolone—Angiopathy—Docetaxel—melanoma	0.000321	0.00174	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Carmustine—melanoma	0.00032	0.00174	CcSEcCtD
Methylprednisolone—Immune system disorder—Docetaxel—melanoma	0.00032	0.00174	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Docetaxel—melanoma	0.000319	0.00173	CcSEcCtD
Methylprednisolone—Pruritus—Bleomycin—melanoma	0.000317	0.00172	CcSEcCtD
Methylprednisolone—Arrhythmia—Docetaxel—melanoma	0.000316	0.00172	CcSEcCtD
Methylprednisolone—Feeling abnormal—Temozolomide—melanoma	0.000312	0.00169	CcSEcCtD
Methylprednisolone—Mental disorder—Docetaxel—melanoma	0.00031	0.00168	CcSEcCtD
Methylprednisolone—Abdominal pain—Carmustine—melanoma	0.00031	0.00168	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Temozolomide—melanoma	0.000309	0.00168	CcSEcCtD
Methylprednisolone—Erythema—Docetaxel—melanoma	0.000308	0.00167	CcSEcCtD
Methylprednisolone—Malnutrition—Docetaxel—melanoma	0.000308	0.00167	CcSEcCtD
Methylprednisolone—Hypersensitivity—Dactinomycin—melanoma	0.000308	0.00167	CcSEcCtD
Methylprednisolone—Urticaria—Temozolomide—melanoma	0.000301	0.00163	CcSEcCtD
Methylprednisolone—Asthenia—Dactinomycin—melanoma	0.0003	0.00163	CcSEcCtD
Methylprednisolone—Abdominal pain—Temozolomide—melanoma	0.000299	0.00162	CcSEcCtD
Methylprednisolone—Hypersensitivity—Carmustine—melanoma	0.000288	0.00157	CcSEcCtD
Methylprednisolone—Diarrhoea—Dactinomycin—melanoma	0.000286	0.00155	CcSEcCtD
Methylprednisolone—Vomiting—Bleomycin—melanoma	0.000285	0.00155	CcSEcCtD
Methylprednisolone—Rash—Bleomycin—melanoma	0.000283	0.00154	CcSEcCtD
Methylprednisolone—Dermatitis—Bleomycin—melanoma	0.000283	0.00153	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP17A1—melanoma	0.000282	0.18	CrCbGaD
Methylprednisolone—Asthenia—Carmustine—melanoma	0.000281	0.00153	CcSEcCtD
Methylprednisolone—Hypersensitivity—Temozolomide—melanoma	0.000279	0.00151	CcSEcCtD
Methylprednisolone—Syncope—Docetaxel—melanoma	0.000276	0.0015	CcSEcCtD
Methylprednisolone—Asthenia—Temozolomide—melanoma	0.000271	0.00147	CcSEcCtD
Methylprednisolone—Loss of consciousness—Docetaxel—melanoma	0.000271	0.00147	CcSEcCtD
Methylprednisolone—Diarrhoea—Carmustine—melanoma	0.000268	0.00145	CcSEcCtD
Methylprednisolone—Pruritus—Temozolomide—melanoma	0.000268	0.00145	CcSEcCtD
Methylprednisolone—Convulsion—Docetaxel—melanoma	0.000267	0.00145	CcSEcCtD
Methylprednisolone—Nausea—Bleomycin—melanoma	0.000266	0.00145	CcSEcCtD
Methylprednisolone—Hypertension—Docetaxel—melanoma	0.000266	0.00145	CcSEcCtD
Methylprednisolone—Vomiting—Dactinomycin—melanoma	0.000266	0.00144	CcSEcCtD
Methylprednisolone—Rash—Dactinomycin—melanoma	0.000264	0.00143	CcSEcCtD
Methylprednisolone—Arthralgia—Docetaxel—melanoma	0.000262	0.00142	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—melanoma	0.000262	0.00142	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000261	0.00142	CcSEcCtD
Methylprednisolone—Dizziness—Carmustine—melanoma	0.000259	0.00141	CcSEcCtD
Methylprednisolone—Diarrhoea—Temozolomide—melanoma	0.000259	0.00141	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—melanoma	0.000254	0.00138	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Docetaxel—melanoma	0.000252	0.00137	CcSEcCtD
Methylprednisolone—Dizziness—Temozolomide—melanoma	0.00025	0.00136	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—melanoma	0.00025	0.00136	CcSEcCtD
Methylprednisolone—Vomiting—Carmustine—melanoma	0.000249	0.00135	CcSEcCtD
Methylprednisolone—Nausea—Dactinomycin—melanoma	0.000248	0.00135	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—melanoma	0.000248	0.00134	CcSEcCtD
Methylprednisolone—Rash—Carmustine—melanoma	0.000247	0.00134	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—melanoma	0.000247	0.00134	CcSEcCtD
Methylprednisolone—Dermatitis—Carmustine—melanoma	0.000247	0.00134	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—melanoma	0.000246	0.00133	CcSEcCtD
Methylprednisolone—Headache—Carmustine—melanoma	0.000245	0.00133	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—melanoma	0.000244	0.00133	CcSEcCtD
Methylprednisolone—Vomiting—Temozolomide—melanoma	0.000241	0.00131	CcSEcCtD
Methylprednisolone—Rash—Temozolomide—melanoma	0.000239	0.0013	CcSEcCtD
Methylprednisolone—Dermatitis—Temozolomide—melanoma	0.000238	0.00129	CcSEcCtD
Methylprednisolone—Headache—Temozolomide—melanoma	0.000237	0.00129	CcSEcCtD
Methylprednisolone—Hypotension—Docetaxel—melanoma	0.000235	0.00128	CcSEcCtD
Methylprednisolone—Nausea—Carmustine—melanoma	0.000233	0.00126	CcSEcCtD
Methylprednisolone—Dexamethasone—NOS2—melanoma	0.00023	0.146	CrCbGaD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000229	0.00124	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—melanoma	0.000228	0.00124	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—melanoma	0.000226	0.00123	CcSEcCtD
Methylprednisolone—Nausea—Temozolomide—melanoma	0.000225	0.00122	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—melanoma	0.000221	0.0012	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—melanoma	0.000217	0.00118	CcSEcCtD
Methylprednisolone—Feeling abnormal—Docetaxel—melanoma	0.000207	0.00113	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—melanoma	0.000206	0.00112	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—melanoma	0.000199	0.00108	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP1B1—melanoma	0.000195	0.124	CrCbGaD
Methylprednisolone—Hypersensitivity—Docetaxel—melanoma	0.000185	0.00101	CcSEcCtD
Methylprednisolone—Asthenia—Docetaxel—melanoma	0.000181	0.00098	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—melanoma	0.000178	0.000966	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—melanoma	0.000172	0.000935	CcSEcCtD
Methylprednisolone—Dizziness—Docetaxel—melanoma	0.000166	0.000903	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—melanoma	0.00016	0.000869	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—melanoma	0.000159	0.000861	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—melanoma	0.000159	0.00086	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—melanoma	0.000158	0.000856	CcSEcCtD
Methylprednisolone—Nausea—Docetaxel—melanoma	0.000149	0.000811	CcSEcCtD
Methylprednisolone—Triamcinolone—PTGS2—melanoma	0.000138	0.0882	CrCbGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.000114	0.00456	CbGpPWpGaD
Methylprednisolone—Betamethasone—PTGS2—melanoma	0.000113	0.0722	CrCbGaD
Methylprednisolone—Prednisone—ALB—melanoma	0.000112	0.0713	CrCbGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—APC—melanoma	0.000112	0.00447	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.00011	0.00441	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	0.000109	0.00437	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.000109	0.00437	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.000107	0.0043	CbGpPWpGaD
Methylprednisolone—Prednisone—ABCB1—melanoma	0.000107	0.068	CrCbGaD
Methylprednisolone—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000106	0.00423	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.000104	0.00418	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.000103	0.00413	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000101	0.00403	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	0.000101	0.00402	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.0001	0.004	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SOCS1—melanoma	9.98e-05	0.004	CbGpPWpGaD
Methylprednisolone—Prednisolone—ABCB1—melanoma	9.83e-05	0.0627	CrCbGaD
Methylprednisolone—Betamethasone—ABCB1—melanoma	9.63e-05	0.0614	CrCbGaD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	9.37e-05	0.00375	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CTLA4—melanoma	9.21e-05	0.00369	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	9.03e-05	0.00362	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	8.92e-05	0.00357	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	8.9e-05	0.00357	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	8.85e-05	0.00355	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—E2F1—melanoma	8.66e-05	0.00347	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IFNG—melanoma	8.64e-05	0.00346	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CLNS1A—melanoma	8.61e-05	0.00345	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	8.51e-05	0.00341	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	8.42e-05	0.00337	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	8.37e-05	0.00335	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	8.17e-05	0.00327	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	8.06e-05	0.00323	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	8.03e-05	0.00322	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—FAS—melanoma	8.02e-05	0.00321	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	7.84e-05	0.00314	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	7.79e-05	0.00312	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	7.74e-05	0.0031	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL2—melanoma	7.67e-05	0.00307	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	7.61e-05	0.00305	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	7.58e-05	0.00304	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	7.57e-05	0.00303	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—HIF1A—melanoma	7.54e-05	0.00302	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SKI—melanoma	7.54e-05	0.00302	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—ABCB1—melanoma	7.52e-05	0.0479	CrCbGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	7.5e-05	0.003	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	7.5e-05	0.003	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCND1—melanoma	7.48e-05	0.003	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	7.41e-05	0.00297	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD86—melanoma	7.3e-05	0.00292	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	7.29e-05	0.00292	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—melanoma	7.26e-05	0.00291	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—PTEN—melanoma	7.22e-05	0.00289	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL10—melanoma	7.16e-05	0.00287	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	7.07e-05	0.00283	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	6.97e-05	0.00279	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL4—melanoma	6.97e-05	0.00279	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	6.93e-05	0.00278	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	6.88e-05	0.00275	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—PDGFRA—melanoma	6.86e-05	0.00275	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-B—melanoma	6.81e-05	0.00273	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	6.79e-05	0.00272	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	6.76e-05	0.00271	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	6.73e-05	0.00269	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	6.71e-05	0.00269	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—FASLG—melanoma	6.66e-05	0.00267	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	6.62e-05	0.00265	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—melanoma	6.59e-05	0.042	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	6.52e-05	0.00261	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	6.44e-05	0.00258	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—FAS—melanoma	6.42e-05	0.00257	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—melanoma	6.41e-05	0.00257	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	6.38e-05	0.00255	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	6.38e-05	0.00255	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	6.34e-05	0.00254	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	6.33e-05	0.00254	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-A—melanoma	6.31e-05	0.00253	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	6.26e-05	0.00251	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	6.21e-05	0.00249	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—RB1—melanoma	6.14e-05	0.00246	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IGF1—melanoma	6.08e-05	0.00244	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	6.03e-05	0.00242	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MYC—melanoma	6e-05	0.0024	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NPPA—melanoma	5.9e-05	0.00236	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	5.77e-05	0.00231	CbGpPWpGaD
Methylprednisolone—Dexamethasone—ABCB1—melanoma	5.6e-05	0.0357	CrCbGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	5.6e-05	0.00224	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	5.58e-05	0.00223	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	5.44e-05	0.00218	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	5.34e-05	0.00214	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD80—melanoma	5.33e-05	0.00213	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	5.17e-05	0.00207	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP8—melanoma	4.95e-05	0.00198	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—melanoma	4.93e-05	0.00197	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	4.74e-05	0.0019	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	4.57e-05	0.00183	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CTNNB1—melanoma	4.51e-05	0.00181	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—melanoma	4.51e-05	0.00181	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CDKN1A—melanoma	4.41e-05	0.00177	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	4.34e-05	0.00174	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	4.29e-05	0.00172	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	4.23e-05	0.00169	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IFNG—melanoma	4.21e-05	0.00169	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	4.15e-05	0.00166	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	4.05e-05	0.00162	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—MDM2—melanoma	3.98e-05	0.00159	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	3.97e-05	0.00159	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—melanoma	3.94e-05	0.00158	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL8—melanoma	3.92e-05	0.00157	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	3.9e-05	0.00156	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	3.78e-05	0.00152	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—melanoma	3.75e-05	0.0015	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL2—melanoma	3.74e-05	0.0015	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	3.73e-05	0.00149	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	3.7e-05	0.00148	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS3—melanoma	3.69e-05	0.00148	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	3.67e-05	0.00147	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	3.67e-05	0.00147	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SNRPE—melanoma	3.63e-05	0.00145	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SKI—melanoma	3.63e-05	0.00145	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.52e-05	0.00141	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	3.49e-05	0.0014	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.47e-05	0.00139	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	3.45e-05	0.00138	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	3.43e-05	0.00138	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	3.42e-05	0.00137	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—melanoma	3.41e-05	0.00136	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	3.38e-05	0.00136	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—VDR—melanoma	3.36e-05	0.00135	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	3.35e-05	0.00134	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	3.29e-05	0.00132	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	3.23e-05	0.00129	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACER3—melanoma	3.2e-05	0.00128	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—melanoma	3.18e-05	0.00127	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	3.17e-05	0.00127	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	3.11e-05	0.00124	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.96e-05	0.00119	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	2.95e-05	0.00118	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	2.94e-05	0.00118	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UGT2B10—melanoma	2.93e-05	0.00117	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.92e-05	0.00117	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NPPA—melanoma	2.84e-05	0.00114	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	2.8e-05	0.00112	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	2.79e-05	0.00112	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—melanoma	2.75e-05	0.0011	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—melanoma	2.73e-05	0.00109	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HS3ST5—melanoma	2.72e-05	0.00109	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.62e-05	0.00105	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.59e-05	0.00104	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	2.48e-05	0.000994	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.44e-05	0.000979	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.4e-05	0.000962	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	2.38e-05	0.000951	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.34e-05	0.000938	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—melanoma	2.34e-05	0.000938	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.32e-05	0.00093	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.21e-05	0.000885	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.1e-05	0.00084	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HDAC2—melanoma	2.08e-05	0.000831	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.07e-05	0.000828	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLCB4—melanoma	2.07e-05	0.000827	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.04e-05	0.000816	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.99e-05	0.000798	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACER3—melanoma	1.97e-05	0.000791	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC6A11—melanoma	1.94e-05	0.000778	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIP4K2A—melanoma	1.94e-05	0.000778	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.9e-05	0.000759	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTAP—melanoma	1.89e-05	0.000756	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.89e-05	0.000756	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.85e-05	0.000741	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UGT2B10—melanoma	1.81e-05	0.000723	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.8e-05	0.000721	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.78e-05	0.000714	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.74e-05	0.000697	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.74e-05	0.000696	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.73e-05	0.000692	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LUM—melanoma	1.68e-05	0.000674	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PHGDH—melanoma	1.68e-05	0.000674	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HS3ST5—melanoma	1.68e-05	0.000672	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CDKN2B—melanoma	1.66e-05	0.000664	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPSE—melanoma	1.65e-05	0.000661	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CUBN—melanoma	1.62e-05	0.000649	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—VDR—melanoma	1.62e-05	0.000648	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.57e-05	0.000628	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SDHD—melanoma	1.57e-05	0.000627	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BSG—melanoma	1.57e-05	0.000627	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CSPG4—melanoma	1.57e-05	0.000627	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPAM—melanoma	1.52e-05	0.000607	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PRKCA—melanoma	1.49e-05	0.000597	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.48e-05	0.000595	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ERCC2—melanoma	1.48e-05	0.000592	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.44e-05	0.000578	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.41e-05	0.000566	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.41e-05	0.000566	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.35e-05	0.000539	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.34e-05	0.000535	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.33e-05	0.000534	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLA2G6—melanoma	1.29e-05	0.000516	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLCB4—melanoma	1.27e-05	0.000509	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.23e-05	0.000491	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC6A11—melanoma	1.2e-05	0.000479	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.2e-05	0.000479	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NOTCH1—melanoma	1.19e-05	0.000478	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.19e-05	0.000475	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTAP—melanoma	1.16e-05	0.000466	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—VCAN—melanoma	1.16e-05	0.000464	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—melanoma	1.13e-05	0.000452	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PHGDH—melanoma	1.04e-05	0.000415	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LUM—melanoma	1.04e-05	0.000415	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPSE—melanoma	1.02e-05	0.000407	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1e-05	0.000401	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CUBN—melanoma	9.98e-06	0.0004	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP17A1—melanoma	9.77e-06	0.000391	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SDHD—melanoma	9.64e-06	0.000386	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BSG—melanoma	9.64e-06	0.000386	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CSPG4—melanoma	9.64e-06	0.000386	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPAM—melanoma	9.34e-06	0.000374	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GNA11—melanoma	9.22e-06	0.000369	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.04e-06	0.000362	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FASN—melanoma	9.03e-06	0.000361	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC5A5—melanoma	8.88e-06	0.000356	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GNAQ—melanoma	8.58e-06	0.000343	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CD44—melanoma	8.58e-06	0.000343	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1B1—melanoma	8.22e-06	0.000329	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLA2G6—melanoma	7.94e-06	0.000318	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—VCAN—melanoma	7.13e-06	0.000286	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK3—melanoma	6.61e-06	0.000265	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—melanoma	6.43e-06	0.000257	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PRKCA—melanoma	6.23e-06	0.00025	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ERCC2—melanoma	6.18e-06	0.000247	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP17A1—melanoma	6.02e-06	0.000241	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GNA11—melanoma	5.68e-06	0.000228	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FASN—melanoma	5.56e-06	0.000223	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC5A5—melanoma	5.47e-06	0.000219	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CD44—melanoma	5.28e-06	0.000212	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GNAQ—melanoma	5.28e-06	0.000212	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1B1—melanoma	5.07e-06	0.000203	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—melanoma	4.88e-06	0.000195	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—melanoma	4.71e-06	0.000189	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—melanoma	4.46e-06	0.000179	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CD—melanoma	4.29e-06	0.000172	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—melanoma	4.24e-06	0.00017	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCB1—melanoma	4.17e-06	0.000167	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PRKCA—melanoma	3.84e-06	0.000154	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ERCC2—melanoma	3.81e-06	0.000152	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CB—melanoma	3.74e-06	0.00015	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—melanoma	3.71e-06	0.000148	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTEN—melanoma	3.23e-06	0.000129	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—melanoma	3.01e-06	0.00012	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—melanoma	2.9e-06	0.000116	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CD—melanoma	2.64e-06	0.000106	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—melanoma	2.61e-06	0.000104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CB—melanoma	2.3e-06	9.23e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—melanoma	2.28e-06	9.14e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—melanoma	2.28e-06	9.13e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTEN—melanoma	1.99e-06	7.97e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—melanoma	1.86e-06	7.46e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—melanoma	1.4e-06	5.62e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—melanoma	1.15e-06	4.59e-05	CbGpPWpGaD
